Best NAD+ Supplements: NMN, NR, Niacin, and How to Choose

The best NAD+ supplement for most adults is a third-party tested nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) product taken at 250 to 1,000 mg a day, because both precursors raise blood NAD+ in published human trials, and NR has the largest body of trial data. Niacin (vitamin B3) raises NAD+ for far less money but causes flushing, while IV NAD+ therapy is a clinic based option with a higher cost and thinner outcome evidence.

NAD+ (nicotinamide adenine dinucleotide) is one of the most critical molecules in your body. It fuels hundreds of enzymatic reactions, drives mitochondrial energy production, supports DNA repair, and regulates cellular aging. The problem: NAD+ levels decline steadily with age. Some estimates suggest that by your 50s you may have about half the NAD+ you had at 20, although measurements vary by tissue and method. By your 60s and beyond, the drop appears to accelerate.

This decline isn’t just a laboratory curiosity. Lower NAD+ levels correlate with reduced energy, slower recovery, cognitive fog, metabolic dysfunction, and accelerated aging at the cellular level. Supplementing with NAD+ precursors has become one of the most popular strategies in longevity medicine, but the options can be confusing. NMN, NR, niacin, IV infusions: which one actually works, and which is right for you?

Why NAD+ Declines and Why It Matters

NAD+ sits at the center of cellular metabolism. It shuttles electrons in the mitochondria to generate ATP (your cell’s energy currency), activates sirtuins (a family of proteins that regulate inflammation, DNA repair, and aging), and serves as a substrate for PARPs (enzymes that repair DNA damage).

The decline happens for several reasons. Chronic inflammation increases the activity of CD38, an enzyme that consumes NAD+. DNA damage accumulates with age, demanding more PARP activity, which also uses NAD+. Meanwhile, the body’s ability to synthesize NAD+ from dietary precursors becomes less efficient over time.

CD38 appears to be a major driver. Camacho-Pereira and colleagues (Cell Metabolism, 2016) reported that CD38 rises with age in mouse tissues and that mice lacking CD38 kept their NAD+ levels and mitochondrial function as they aged. Human data on CD38 are still limited.

The result is an energy deficit at the cellular level. Your mitochondria produce less ATP. Your DNA repair slows. Sirtuin activity drops. This cascade contributes to many of the symptoms people associate with “normal aging,” including fatigue, brain fog, slower recovery from exercise or illness, and metabolic changes like insulin resistance.

How does the body make NAD+?

The body makes NAD+ through three routes. The de novo pathway builds it from the amino acid tryptophan through the kynurenine pathway. The Preiss-Handler pathway converts nicotinic acid (niacin). The salvage pathway recycles nicotinamide back into NMN through the enzyme NAMPT, and it supplies most of the NAD+ in human tissues. Each supplement in the sections below feeds one of these routes.

The Three Main NAD+ Precursors

Your body can make NAD+ from several precursor molecules. The three that matter most for supplementation are NMN, NR, and niacin. Each enters the NAD+ biosynthesis pathway at a different point, and each has distinct advantages and drawbacks.

NMN (Nicotinamide Mononucleotide)

NMN is one enzymatic step away from NAD+ itself. In the biosynthesis pathway, NMN is converted directly to NAD+ by the enzyme NMNAT. This proximity to the end product is one of the reasons NMN has attracted so much attention, particularly from Dr. David Sinclair’s lab at Harvard, which has published extensively on NMN’s effects in animal models.

There was a longstanding debate about whether NMN could enter cells directly or needed to be converted to NR first. In 2019, researchers identified a transporter called Slc12a8 in the gut that appears to allow direct NMN uptake, at least in mice, according to Grozio and colleagues in Nature Metabolism. The relevance of this transporter in humans is still being studied, but several human trials have now confirmed that oral NMN supplementation does raise blood NAD+ levels.

Published human trials show NMN at doses of 250 to 1,250 mg per day increases NAD+ metabolites in blood, improves muscle insulin sensitivity in older adults, and may improve aerobic capacity. A 2021 study in Science by Yoshino and colleagues at Washington University in St. Louis showed NMN improved muscle insulin sensitivity and remodeling in postmenopausal women with prediabetes. The aerobic capacity signal comes from a randomized trial in amateur runners by Liao and colleagues (Journal of the International Society of Sports Nutrition, 2021).

Typical dose: 250 to 1,000 mg daily.
Cost: $40 to $80 per month for quality brands.
Form: Capsules, sublingual powder, or enteric-coated tablets.

NR (Nicotinamide Riboside)

NR enters the NAD+ pathway through the NRK1 enzyme, which converts it to NMN, which is then converted to NAD+. So NR is two steps away from NAD+, compared to NMN’s one step. This doesn’t necessarily make it less effective. The NRK1 pathway is well-established and highly efficient in human cells.

NR’s biggest advantage is its clinical evidence base. Niagen, the patented form of NR made by ChromaDex, has been used in more published human clinical trials than any other NAD+ precursor. These studies have consistently shown that NR at 300 to 1,000 mg daily raises whole blood NAD+ levels by 40 to 90%, with good safety profiles across study durations of up to 12 weeks.

NR has also shown benefits in specific clinical populations. Studies have demonstrated improvements in blood pressure, arterial stiffness, and exercise performance in older adults. A trial in heart failure patients showed favorable changes in mitochondrial respiration. Research in Parkinson’s disease patients showed increased brain NAD+ levels on MRI spectroscopy.

Those findings are early. The blood pressure and arterial stiffness signal in Martens and colleagues (Nature Communications, 2018) was a secondary finding in a small pilot trial, and the NADPARK Parkinson’s study by Brakedal and colleagues (Cell Metabolism, 2022) was a phase I trial designed to test safety and brain uptake rather than symptom relief.

Typical dose: 300 to 1,000 mg daily.
Cost: $30 to $60 per month (Tru Niagen is the most widely available brand).
Form: Capsules.

Niacin (Vitamin B3 / Nicotinic Acid)

Niacin is the original NAD+ precursor, and it’s dirt cheap. Your body converts niacin to NAD+ through the Preiss-Handler pathway, a well-characterized biochemical route that has been understood for decades. At doses of 500 to 1,000 mg, niacin reliably increases NAD+ levels.

The catch is flushing. Niacin activates a receptor called GPR109A on skin cells, triggering the release of prostaglandins that cause intense redness, warmth, and tingling, usually in the face and upper body. This effect is harmless but uncomfortable, and it causes many people to stop taking niacin. Extended-release formulations reduce flushing but carry a small risk of liver toxicity at high doses.

Nicotinamide (also called niacinamide) is a related form that doesn’t cause flushing, but at high doses it can inhibit sirtuin activity, which partially defeats the purpose of raising NAD+ in the first place.

Doses of 500 to 1,000 mg sit far above the nutritional need for niacin. The NIH Office of Dietary Supplements niacin fact sheet lists a recommended dietary allowance of 16 mg a day for adult men and 14 mg a day for adult women, and an upper limit of 35 mg a day from supplements. At precursor doses, niacin behaves like a drug, which is why prescription niacin is managed by physicians.

Typical dose: 500 to 1,000 mg daily (start low, build up to manage flushing).
Cost: $5 to $15 per month.
Form: Tablets, extended-release tablets.

Head-to-Head Comparison

NR has the most published human data, NMN sits one enzymatic step closer to NAD+, and niacin is the cheapest precursor with the most side effects. All three raise NAD+ by mouth, and none has long-term trials showing it slows aging in people.

Do NAD+ Supplements Work? What Human Trials Show

NAD+ supplements reliably raise NAD+ and its metabolites in blood, and that part of the evidence is consistent across trials. Whether higher blood NAD+ translates into more energy, better metabolism or slower aging in people is far less settled. Most human trials are small, last weeks rather than years, and measure biomarkers rather than how people feel or how long they live.

The results so far are mixed, as the trials below show.

NR and NMN are supported by good biomarker data and a few encouraging clinical signals. Claims that they extend lifespan in people rest mainly on animal research, including work from the Sinclair lab at Harvard and the Imai lab at Washington University in St. Louis.

Brand Comparison: Who Makes What

The NAD+ precursor market is crowded, and product quality varies enormously. The products below appear often in retail listings and in the research literature, and the table records what each label and maker state about dose and testing. Treat it as a reading aid for comparing labels, not as a recommendation of any brand.

How to Choose a NAD+ Supplement: A Step by Step Checklist

Choosing a NAD+ supplement comes down to the precursor, the label dose, independent testing and your health history.

1. Pick the precursor that matches your priority. NR has the largest trial record, NMN is one step closer to NAD+, and niacin is the low cost option for people who can tolerate flushing.
2. Check that the label dose matches the trials. Most NMN and NR trials used 250 to 1,000 mg a day, so a product far below that range is unlikely to match the studied effect.
3. Look for a named third-party certification. An NSF, USP or ConsumerLab mark, or a current certificate of analysis from an independent lab, confirms that the capsule contains what the label says.
4. Review your medications and conditions with a clinician. Diabetes, gout, liver disease, an active cancer and statin therapy all change the risk picture, especially for niacin.
5. Start low, record a baseline and give it time. Note your energy, sleep or lab values, begin at the low end of the range, and allow 4 to 8 weeks before judging the result.

Dosing Recommendations

There is no FDA-established dose for NMN or NR as NAD+ boosters. Recommendations are based on published clinical trials, pharmacokinetic data, and clinical experience from practitioners working in longevity medicine.

NMN: Most human trials have used 250 to 1,250 mg daily. A reasonable starting dose is 250 to 500 mg in the morning (NAD+ is involved in circadian rhythm regulation, so morning dosing aligns with your body’s natural cycle). Some people titrate up to 1,000 mg based on response.

NR: Clinical trials typically use 300 to 1,000 mg daily. Tru Niagen’s standard dose is 300 mg, but many longevity practitioners recommend 600 to 1,000 mg for therapeutic purposes. Like NMN, morning dosing is generally preferred.

Niacin: Start at 100 to 250 mg with food and increase gradually over weeks. The flushing response diminishes with consistent daily use. Taking an aspirin 30 minutes before your dose can reduce flushing. Extended-release niacin should be capped at 1,500 mg daily due to liver concerns, and liver function should be monitored periodically.

For a dose by dose walk through, including how doses differ for injections and infusions, see our NAD+ dosage guide.

Liposomal, Sublingual and Oral NAD+: Does the Form Matter?

Delivery form matters less than the precursor and the dose. Capsules of NR and NMN were used in most published trials, so they have the clearest evidence.

Sublingual NMN, dissolved under the tongue, is marketed as bypassing digestion. Human trials comparing it with swallowed NMN are scarce, so that advantage is plausible rather than demonstrated.

Products sold as oral or liposomal NAD+ itself face a bigger hurdle. The gut largely breaks NAD+ down into smaller precursors such as nicotinamide, NMN and NR before absorption, and published human data on liposomal NAD+ are thin.

Oral Supplements vs. IV NAD+ Infusions

Oral precursors are convenient and relatively affordable for daily use. But they have inherent limitations. First-pass metabolism in the liver means a significant portion of the ingested precursor is processed before reaching systemic circulation. The conversion efficiency from precursor to NAD+ varies between individuals based on enzyme activity, gut health, and other factors.

IV NAD+ infusions deliver the molecule directly into the bloodstream, completely bypassing digestion and first-pass metabolism. The result is a rapid, substantial spike in circulating NAD+ that oral supplements do not produce. Many patients report noticeable improvements in energy, mental clarity, and overall well-being during or shortly after an infusion series, although these are patient reports rather than results from controlled trials.

The tradeoff is cost ($250 to $1,000 per infusion), time (infusions typically take 2 to 4 hours), and access (you need a clinic that offers them). IV NAD+ can also cause nausea, chest tightness, and cramping during the infusion, especially at higher doses or faster drip rates. These effects are temporary and manageable by adjusting the infusion speed.

IV NAD+ therapy, also called an NAD+ drip or NAD+ infusion, is cash pay in most clinics and is not FDA approved for aging, fatigue or addiction recovery. Infusions are usually ordered by a physician or nurse practitioner and given by a registered nurse, often in integrative, functional medicine or IV therapy clinics. Our guide to NAD+ IV therapy covers how a session runs, and the comparison of IV NAD+ and oral supplements looks at the tradeoffs in more depth.

Where to Find NAD+ IV Therapy and Clinician Guidance

NAD+ IV therapy is offered by IV therapy, integrative medicine and longevity clinics across the US, and the Regenerated.com directory lists clinics that offer NAD+ IV therapy by state and city. People who are exploring NAD+ for persistent symptoms, such as those living with chronic fatigue syndrome or long COVID, usually do best starting with a clinician who can rule out other causes first.

Regenerated.com is free for patients. Listing order is not paid ranking, Featured slots are labeled and capped, and Verified means the clinic completed credential checks, not that it paid for placement. Inclusion in the directory is not an endorsement, and our explanation of Featured, Verified and organic listings sets out how each label works.

Before booking, ask who orders and monitors the infusion and whether your medications are reviewed first. A well run clinic answers those questions plainly.

Combination Strategies

Some practitioners and longevity researchers recommend pairing NAD+ precursors with complementary compounds for synergistic effects.

NMN + TMG (trimethylglycine): NMN and NR metabolism produces nicotinamide as a byproduct. Clearing nicotinamide requires methylation, which consumes methyl groups. TMG donates methyl groups, supporting this clearance pathway and preventing potential methyl donor depletion. Many NMN users take 500 to 1,000 mg of TMG alongside their NMN dose.

NMN or NR + Resveratrol: David Sinclair’s research suggests that resveratrol activates sirtuins, while NAD+ serves as the fuel sirtuins need to function. The analogy is that resveratrol is the gas pedal and NAD+ is the fuel. Whether this combination produces meaningful clinical benefits in humans beyond what either compound does alone is still an open question, but the mechanistic rationale is plausible.

NAD+ precursor + Apigenin or Quercetin: These flavonoids inhibit CD38, the enzyme that breaks down NAD+. By slowing NAD+ degradation while simultaneously boosting production with a precursor, you may get more out of each dose. Apigenin (found in chamomile) and quercetin (found in onions and apples) are available as supplements, typically dosed at 50 to 500 mg daily.

Published randomized trials comparing these stacks with the precursor alone are scarce or absent, so the reasoning comes mainly from biochemistry and animal work. Quercetin also appears in senolytic research, which our overview of regenerative medicine and longevity covers alongside other longevity strategies.

Safety Considerations

What are the risks of high dose niacin?

High dose niacin carries more risk than NMN or NR. According to the NIH Office of Dietary Supplements, doses well above the upper limit can raise blood sugar and uric acid, which matters for people with diabetes or gout. People taking a statin should combine it with niacin only under medical supervision, because the pairing can raise the risk of muscle problems.

Niacin was once widely prescribed to raise HDL cholesterol. Two large randomized trials, AIM-HIGH (New England Journal of Medicine, 2011) and HPS2-THRIVE (New England Journal of Medicine, 2014), found that adding niacin to statin therapy did not lower cardiovascular events, and HPS2-THRIVE recorded more serious side effects. In 2024, Cleveland Clinic researchers led by Ferrell reported in Nature Medicine that high blood levels of a niacin breakdown product, 4PY, were associated with higher cardiovascular risk. That is an association, not proof of harm, but it is a reason not to take large niacin doses without a clinician.

Who should talk to a clinician before taking a NAD+ supplement?

People who are pregnant or breastfeeding, have an active cancer, have liver disease, diabetes or gout, or take statins or chemotherapy should talk with a physician or pharmacist first. Human safety data for NMN and NR in pregnancy and in children are essentially absent.

How NAD+ Supplements Are Regulated in the US

NMN, NR and niacin are sold in the US as dietary supplements under the Dietary Supplement Health and Education Act of 1994 (DSHEA). Under that law the FDA does not review supplements for safety or effectiveness before they go on sale; makers are responsible for their own products, and the Federal Trade Commission polices misleading advertising.

NMN has had an unusual path. In 2022 the FDA took the position that NMN could not be marketed as a supplement because it had first been studied as a drug, and the agency later reversed that position, which is why the comparison table lists NMN as a supplement. IV NAD+ is usually compounded and given off label.

Bottom Line: How to Choose

If evidence base is your top priority, start with NR. It has the most robust human clinical trial data, products with NSF certification are available, and the dosing protocol is straightforward.

If you want to be closer to the cutting edge and you’re comfortable with a slightly smaller (but growing) evidence base, NMN is a strong choice. Sublingual forms may offer better absorption. Pair with TMG for methylation support.

If cost is the primary concern and you can tolerate flushing, niacin raises NAD+ effectively for pennies a day. It’s not glamorous, but it does raise NAD+, and at precursor doses it needs a clinician’s oversight.

If you’re dealing with significant health challenges or want rapid results, consider IV NAD+ infusions for initial restoration, then transition to daily oral precursors for maintenance. You can compare providers in the NAD+ IV therapy clinic directory.

Whatever you choose, buy from brands that provide third-party testing data, start at the lower end of the dosing range, and give any supplement at least 4 to 8 weeks before evaluating results. NAD+ restoration is a gradual process, not an overnight fix.

Frequently asked questions

What is the best NAD+ supplement to take?

For most adults the best NAD+ supplement is a third-party tested NR or NMN product at 250 to 1,000 mg a day. NR has the largest number of published human trials, and NMN has a smaller but growing set, including a 2021 trial in Science. Niacin raises NAD+ for less money but causes flushing and needs medical oversight at precursor doses. Check for an NSF, USP or ConsumerLab mark before you buy.

Is NMN or NR better for raising NAD+?

Neither NMN nor NR has been shown to be clearly better for raising NAD+ in people. Both raise blood NAD+ in human trials at 250 to 1,000 mg a day. NR has more published trials, while NMN sits one enzymatic step closer to NAD+. Direct head to head human trials are scarce, so the choice usually comes down to evidence comfort, price and product quality. Our NMN vs NR comparison covers the details.

How much NAD+ supplement should I take a day?

Most human trials used 250 to 1,250 mg of NMN or 300 to 1,000 mg of NR a day. A common approach is to start at 250 to 500 mg of NMN or 300 mg of NR in the morning and adjust with a clinician. Niacin is different: the NIH upper limit for supplements is 35 mg a day, so the 500 to 1,000 mg doses used to raise NAD+ belong under medical supervision.

Do NAD+ supplements have side effects?

NAD+ supplements usually cause mild side effects at studied doses. NMN and NR occasionally cause stomach upset, headache or fatigue, and trials of up to about 12 weeks have reported good tolerability. Niacin commonly causes flushing and, at high doses, can strain the liver and raise blood sugar. IV NAD+ can cause nausea, chest pressure and cramping during the drip, which usually eases when the infusion is slowed.

Is IV NAD+ better than taking NMN or NR by mouth?

IV NAD+ raises blood NAD+ faster than oral NMN or NR, but there is no good evidence that it produces better long-term results. Infusions take 2 to 4 hours, are cash pay, and are not FDA approved for aging or fatigue. Oral precursors have more controlled trial data and suit daily maintenance. Some people combine a short infusion series with daily oral precursors, ideally with a clinician tracking the response.

How long does it take for NAD+ supplements to work?

NAD+ supplements raise blood NAD+ within days to weeks in trials, but noticeable changes in energy or recovery, if they come, usually take longer. A fair trial is 4 to 8 weeks at a consistent dose, judged against notes you made before starting. If nothing has changed after 2 to 3 months, a different precursor, a clinician review or a look at other causes of fatigue makes more sense than a higher dose.

Sources

1. Yoshino J, Baur JA, Imai SI. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. 2018;27(3):513-528. doi:10.1016/j.cmet.2017.11.002
2. Grozio A, Mills KF, Yoshino J, et al. Slc12a8 is a nicotinamide mononucleotide transporter. Nat Metab. 2019;1(1):47-57. doi:10.1038/s42255-018-0009-4
3. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. doi:10.1126/science.abe9985
4. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. doi:10.1038/s41467-018-03421-7
5. Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Rep. 2019;28(7):1717-1728. doi:10.1016/j.celrep.2019.07.043
6. Trammell SA, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016;7:12948. doi:10.1038/ncomms12948
7. Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9(1):9772. doi:10.1038/s41598-019-46120-z
8. Brakedal B, Dolle C, Riber F, et al. The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease. Cell Metab. 2022;34(3):396-407. doi:10.1016/j.cmet.2022.02.001
9. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 2016;23(6):1127-1139.
10. Dollerup OL, Christensen B, Svart M, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018;108(2):343-353.
11. Liao B, Zhao Y, Wang D, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021;18(1):54.
12. AIM-HIGH Investigators, Boden WE, Probstfield JL, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365(24):2255-2267.
13. HPS2-THRIVE Collaborative Group, Landray MJ, Haynes R, et al. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med. 2014;371(3):203-212.
14. Ferrell M, Wang Z, et al. A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. Nat Med. 2024.
15. NIH Office of Dietary Supplements. Niacin: fact sheet for health professionals.

Related Reading

• NAD+ IV Therapy: The Complete Guide
• NMN vs NR: Which NAD+ Precursor Is Better?
• IV Therapy: Benefits, Risks, and What the Science Says
• Regenerative Medicine and Longevity
• Vitamin D Optimization: Getting Your Levels Right